["{\n\"step_by_step_thinking\": \"There is no information provided about LB-100 or its effects on ovarian carcinoma. The documents only discuss cisplatin and its comparison with other platinum compounds, as well as cisplatin-based combination chemotherapy in the treatment of stage III ovarian epithelial tumors of low malignant potential. Therefore, it cannot be determined whether LB-100 can sensitize ovarian carcinoma to cisplatin based on the provided information.\",\n\"answer_choice\": \"B\""]